Response Genetics (RGDXQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,540 | 12,270 | 15,120 | 17,530 | 17,020 |
| Receivables | 2,110 | 700 | 630 | 920 | 4,200 |
| Other current assets | 410 | 600 | 640 | 790 | 570 |
| TOTAL | $12,060 | $13,570 | $16,390 | $19,240 | $21,790 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 60 | 70 | 10 | 20 | 20 |
| TOTAL | $60 | $70 | $10 | $20 | $20 |
| Total Assets | $13,540 | $16,400 | $19,290 | $22,000 | $24,410 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 540 | 710 | 1,040 | 690 | 230 |
| Accrued Expenses | 1,190 | 1,170 | 810 | 950 | 1,090 |
| Other current liabilities | 2,580 | 1,890 | 1,550 | 1,990 | 7,190 |
| TOTAL | $4,320 | $3,780 | $3,400 | $3,640 | $8,510 |
| Non-Current Liabilities | |||||
| TOTAL | $2,350 | $2,490 | $4,030 | $4,660 | $790 |
| Total Liabilities | $6,670 | $6,280 | $7,440 | $8,300 | $9,300 |
| Shareholders' Equity | |||||
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -29,800 | -26,410 | -24,210 | -22,040 | -20,320 |
| Other shareholders' equity | -230 | -120 | -40 | -40 | -30 |
| TOTAL | $6,870 | $10,110 | $11,850 | $13,690 | $15,100 |
| Total Liabilities And Equity | $13,540 | $16,390 | $19,290 | $21,990 | $24,400 |